CLINICAL_TRIALS
trial_result
· 2014-04-25
Clinical Trial Update: Melphalan and Panobinostat (LBH589) for the Treatment of Patients With Recurrent Multiple Myeloma [Phase 1, Phase 2]
Summary
Results from a Phase 1/2 trial evaluating the combination of melphalan and panobinostat (LBH589) in patients with recurrent multiple myeloma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Oncotherapeutics | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-04-25